Leqembi

Biogen's monoclonal antibody for Alzheimer's disease.

Pharma

Merck-Kelun, China deal wisdom, Takeda—Fierce Pharma Asia

Merck and Kelun's sac-TMT reported three positive phase 3s. Experts talk useful tools in China dealmaking. Takeda was hit with a pay-for-delay verdict.

Angus Liu May 22, 2026 8:53am

Eisai's push toward blockbuster Leqembi sales gains steam

May 15, 2026 11:35am

Graphic image of puzzle pieces missing from a persons brain a symbol of degeneration andor the improvement of it

Anti-amyloid Alzheimer's drugs show 'trivial' effects: report

Apr 16, 2026 11:36am

Takeda, Innovent-Lilly, Roche—Fierce Pharma Asia

Oct 31, 2025 8:20am

Biogen ticks up sales outlook again as MS franchise holds strong

Oct 30, 2025 1:37pm

Gilead, Eisai, Vertex meds make Time's list of best inventions

Oct 10, 2025 11:58am